ANI Pharmaceuticals | ANIP - Cash And Equivalent

Stock Price
74.52
Daily Change
0.24 0.32%
Monthly
-4.58%
Yearly
14.88%
Q1 Forecast
68.36

ANI Pharmaceuticals reported $285.58M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.23B 400M Dec/2025
ANI Pharmaceuticals USD 285.58M 22.98M Dec/2025
Assertio Holdings USD 38.5M 8.59M Sep/2025
Aurora Cannabis CAD 95.69M 44.47M Sep/2025
Canopy Growth CAD 298.06M 171.86M Sep/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Emergent BioSolutions USD 111.7M 23.9M Dec/2023
Heron Therapeutics USD 43.07M 26.55M Sep/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Knight Therapeutics CAD 81.88M 4.06M Sep/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Omeros USD 1.9M 2.36M Jun/2025
Perrigo USD 432.1M 22.1M Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025